期刊文献+

泌尿生殖道假丝酵母菌病患者的菌种鉴定及耐药性探讨 被引量:5

Species Identification and Drug Resistance from Patients with Urogenital Candidiasis
下载PDF
导出
摘要 目的探讨泌尿生殖道假丝酵母菌病真菌构成及耐药。方法采用常规方法进行真菌培养,用科玛嘉显色培养基及API 20C AUX鉴定条进行鉴定,药敏试验采用NCCLS推荐的M27-A微量肉汤稀释法。结果分离的331株真菌中,以白色假丝酵母菌为主,占85.5%,其次是光滑假丝酵母菌5.7%、近平滑假丝酵母菌4.5%;女性患者,耐药率分别为伊曲康唑3.24%、氟康唑4.32%、制霉菌素4.86%、两性霉素B 6.49%、咪康唑16.76%、酮康唑17.84%、益康唑28.65%;男性患者,耐药率分别为制霉菌素4.11%、伊曲康唑5.48%、氟康唑8.22%、两性霉素B 10.27%、酮康唑17.81%、益康唑23.29%、咪康唑26.71%。结论应重视生殖道假丝酵母菌病真菌的培养鉴定和药敏试验,以指导临床合理选择抗真菌药物。 OBJECTIVE To investigate species and drug resistance of pathogenic fungi from patients with urogenital candidiasis. METHODS The fungi were cultured with general method, isolated and identified with CHRO-Magar medium and API20C AUX stripes. Drug sensitive test was tested by M-27-A broth microdilution method recommendated. RESULTS In 331 pathogenic fungi, C. albicans was the most frequent species, followed by C. glabrata and C. parapsilosis. The resistant rate in the female patients was: to itraconazole 3. 24%, fluconazole 4.32%, nystatin 4.86%, amphotericin B 6.49%, miconazole 16.76%, ketoconazole 17.84%, and to econazole 28.6%, and that in the male patients was.. to nystatin 4. 11%, itraconazole 5. 48%, fluconazole 8. 22%, amphotericin B 10. 27%, ketoconazole 17.81%, econazole 23.29% and to rniconazole 26. 71%. CONCLUSIONS In order to guide clinically the selection of reasonable antifungals, species identification and sensitive test should also be stressed.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第5期744-746,共3页 Chinese Journal of Nosocomiology
关键词 生殖道假丝酵母菌病 耐药性 药敏试验 Genital candidiasis Drug resistance Drug sensitive test
  • 相关文献

参考文献5

二级参考文献18

  • 1王文莉,王端礼,李世荫,李若瑜,万哲,王晓红.NCCLS方案检测氟康唑对酵母菌的最小抑菌浓度[J].中华皮肤科杂志,1996,29(5):374-376. 被引量:13
  • 2Houang ETS, Chu KC, Koehler AP, et al. Use of CHROMagar Candida for genital specimens in the diagnostic laboratory[J].J Clin Pathol, 1997, 50 (7): 563-565.
  • 3Abdullah AN, Drake SM, Wade AA, et aI. Balanitis (balanoposthitis) in patients attending a department of genitourinary medicine[J] .Inter J STD & AIDS, 1992,3(2):128-129.
  • 4McCutchan J A,Ronald A R.Evaluation of new anti infective drugs for treatment of vaginal infections[J].Clin Infect Dis,1998,15:115-119.
  • 5Burnhill M S.Infections diseases in obstetrics and gynecology[J].IDI Publicat,1999,11:21-26.
  • 6熊杰.一种酵母菌快速鉴定方法的评价[J].成都军区医院学报,2004,2:26-27.
  • 7Hammer K A,Carson C F,Riley T V.In vitro activities of Ketoconazole,Econazole,and Melaleuca alternifolia(Tea Tree) oil against malassezia species[J].Antimicrob Agents Chemother,2003,44:467-469.
  • 8Arikan S,Akova M,Hayran M,et al.Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis[J].Clin Infect Dis,1998,26:903-908.
  • 9Rex J H,Pfaller M A,Galgiani J N,et al.Develofpmenointerpretive break-points for antifungal susceptibility testing:conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole,itraconazole,and candida infections.Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards[J].Clin Infect Dis,2004,24:235-247.
  • 10De repentigny,Phaneuf L M.Gastrointestion colonization and systemic dissemination by Candida albicans and Candida tropicalis inintact and immun-compromi sed mice[J].Infect Immun,2002,60:4907-4912

共引文献15

同被引文献24

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部